Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study

The aim of this multi-center, open-label, randomized, parallel-group trial was to compare the efficacy of rosuvastatin with that of simvastatin in achieving the 1998 European Atherosclerosis Society (EAS) lipid treatment goals. 504 patients (≥18 years) with primary hypercholesterolemia and a 10-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Laks, Toivo, Keba, Ester, Leiner, Mariann, Merilind, Eero, Petersen, Mall, Reinmets, Sirje, Väli, Sille, Sööt, Terje, Otter, Karin
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663459/
https://www.ncbi.nlm.nih.gov/pubmed/19337553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663459/
https://www.ncbi.nlm.nih.gov/pubmed/19337553

Ejemplares similares